Van Tendeloo VF - Search Results

1

Quantification of IFN-gamma produced by human purified NK cells following tumor cell stimulation: comparison of three IFN-gamma assays.

Lion E, Smits EL, Berneman ZN, Van Tendeloo VF. Lion E, et al. Among authors: van tendeloo vf. J Immunol Methods. 2009 Oct 31;350(1-2):89-96. doi: 10.1016/j.jim.2009.08.014. Epub 2009 Sep 4. J Immunol Methods. 2009. PMID: 19733573

2

Natural killer cell immune escape in acute myeloid leukemia.

Lion E, Willemen Y, Berneman ZN, Van Tendeloo VF, Smits EL. Lion E, et al. Among authors: van tendeloo vf. Leukemia. 2012 Sep;26(9):2019-26. doi: 10.1038/leu.2012.87. Epub 2012 Mar 26. Leukemia. 2012. PMID: 22446501 Review.

3

Cancer immunotherapy using RNA-loaded dendritic cells.

Ponsaerts P, Van Tendeloo VF, Berneman ZN. Ponsaerts P, et al. Among authors: van tendeloo vf. Clin Exp Immunol. 2003 Dec;134(3):378-84. doi: 10.1046/j.1365-2249.2003.02286.x. Clin Exp Immunol. 2003. PMID: 14632740 Free PMC article. Review.

4

Ex vivo induction of viral antigen-specific CD8 T cell responses using mRNA-electroporated CD40-activated B cells.

Van den Bosch GA, Ponsaerts P, Nijs G, Lenjou M, Vanham G, Van Bockstaele DR, Berneman ZN, Van Tendeloo VF. Van den Bosch GA, et al. Among authors: van tendeloo vf, van bockstaele dr. Clin Exp Immunol. 2005 Mar;139(3):458-67. doi: 10.1111/j.1365-2249.2005.02733.x. Clin Exp Immunol. 2005. PMID: 15730391 Free PMC article.

5

Current challenges in human embryonic stem cell research: directed differentiation and transplantation tolerance.

Ponsaerts P, van Tendeloo VF, Jorens PG, Berneman ZN, van Bockstaele DR. Ponsaerts P, et al. Among authors: van tendeloo vf, van bockstaele dr. J Biol Regul Homeost Agents. 2004 Jul-Dec;18(3-4):347-51. J Biol Regul Homeost Agents. 2004. PMID: 15786703 Review.

6

Proinflammatory response of human leukemic cells to dsRNA transfection linked to activation of dendritic cells.

Smits EL, Ponsaerts P, Van de Velde AL, Van Driessche A, Cools N, Lenjou M, Nijs G, Van Bockstaele DR, Berneman ZN, Van Tendeloo VF. Smits EL, et al. Among authors: van tendeloo vf, van driessche a, van de velde al, van bockstaele dr. Leukemia. 2007 Aug;21(8):1691-9. doi: 10.1038/sj.leu.2404763. Epub 2007 May 24. Leukemia. 2007. PMID: 17525722

7

Immunosuppression induced by immature dendritic cells is mediated by TGF-beta/IL-10 double-positive CD4+ regulatory T cells.

Cools N, Van Tendeloo VF, Smits EL, Lenjou M, Nijs G, Van Bockstaele DR, Berneman ZN, Ponsaerts P. Cools N, et al. Among authors: van tendeloo vf, van bockstaele dr. J Cell Mol Med. 2008 Apr;12(2):690-700. doi: 10.1111/j.1582-4934.2007.00084.x. J Cell Mol Med. 2008. PMID: 18419605 Free PMC article.

8

Interferon-α in acute myeloid leukemia: an old drug revisited.

Anguille S, Lion E, Willemen Y, Van Tendeloo VF, Berneman ZN, Smits EL. Anguille S, et al. Among authors: van tendeloo vf. Leukemia. 2011 May;25(5):739-48. doi: 10.1038/leu.2010.324. Epub 2011 Jan 28. Leukemia. 2011. PMID: 21274002 Review.

9

Characterization of Interleukin-15-Transpresenting Dendritic Cells for Clinical Use.

Van den Bergh JMJ, Smits ELJM, Versteven M, De Reu H, Berneman ZN, Van Tendeloo VFI, Lion E. Van den Bergh JMJ, et al. J Immunol Res. 2017;2017:1975902. doi: 10.1155/2017/1975902. Epub 2017 Jul 13. J Immunol Res. 2017. PMID: 28785596 Free PMC article.

10

Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties.

Anguille S, Smits EL, Cools N, Goossens H, Berneman ZN, Van Tendeloo VF. Anguille S, et al. Among authors: van tendeloo vf. J Transl Med. 2009 Dec 18;7:109. doi: 10.1186/1479-5876-7-109. J Transl Med. 2009. PMID: 20021667 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

108 results

Search Page